We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

Back to rankings

157 hedge funds and large institutions have $2B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2014 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 65 increasing their positions, 42 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 42

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more funds holding

Funds holding: 154 → 157 (+3)

5% more capital invested

Capital invested by funds: $1.91B → $2B (+$90M)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

45% less call options, than puts

Call options by funds: $1.31M | Put options by funds: $2.36M

Holders
157
Holders Change
+3
Holders Change %
+1.95%
% of All Funds
4.56%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.12%
New
22
Increased
65
Reduced
42
Closed
19
Calls
$1.31M
Puts
$2.36M
Net Calls
-$1.06M
Net Calls Change
-$3.01M

Top Buyers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
+$55.5M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$31.8M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$27.1M
4
MAA
Managed Account Advisors
New Jersey
+$9M
5
William Blair & Company
William Blair & Company
Illinois
+$8.74M

Top Sellers

Rank Fund Capital Flow
1
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$63.6M
2
CCM
Consonance Capital Management
New York
-$37.6M
3
JP Morgan Chase
JP Morgan Chase
New York
-$27.5M
4
BCIM
Black Creek Investment Management
Ontario, Canada
-$26.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$25.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
26
Visium Asset Management
New York
$15.3M -$4.77M -139,039 -24%
RG
27
Renaissance Group
Kentucky
$14.3M +$1.15M +33,588 +9%
PPA
28
Parametric Portfolio Associates
Washington
$13.3M -$2.08M -60,623 -14%
CCM
29
Century Capital Management
Massachusetts
$12.9M -$6.46M -188,410 -34%
GPGA
30
Grandeur Peak Global Advisors
Utah
$12.6M +$2.17M +63,350 +21%
CS
31
Credit Suisse
Switzerland
$10.8M +$2.17M +63,419 +26%
Brown Advisory
32
Brown Advisory
Maryland
$9.96M +$4.61M +134,549 +90%
Two Sigma Investments
33
Two Sigma Investments
New York
$9.78M +$2.18M +63,706 +30%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$9.5M +$1.7M +49,500 +22%
Millennium Management
35
Millennium Management
New York
$9.04M +$5.69M +166,109 +180%
Morgan Stanley
36
Morgan Stanley
New York
$9.02M +$1.86M +54,278 +27%
LBA
37
Letko, Brosseau & Associates
Quebec, Canada
$8.76M – – –
WHG
38
Westwood Holdings Group
Texas
$8.54M +$288K +8,398 +4%
Renaissance Technologies
39
Renaissance Technologies
New York
$8.24M +$3.7M +107,800 +85%
JAM
40
Jupiter Asset Management
United Kingdom
$8.08M +$908K +26,500 +13%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$8M -$1.99M -58,007 -20%
Marshall Wace
42
Marshall Wace
United Kingdom
$7.13M +$1.82M +52,956 +35%
BAMCO Inc
43
BAMCO Inc
New York
$7.06M – – –
PC
44
Pier Capital
Connecticut
$6.88M -$77.2K -2,251 -1%
JP Morgan Chase
45
JP Morgan Chase
New York
$6.74M -$27.5M -801,614 -81%
MCM
46
McKinley Capital Management
Alaska
$6.61M -$994 -29 -0%
Barclays
47
Barclays
United Kingdom
$6.47M +$2.02K +59 +0%
ACI
48
AMP Capital Investors
Australia
$6.41M +$1.6M +46,700 +33%
CCM
49
Causeway Capital Management
California
$6.33M +$1.87M +54,700 +43%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$6.2M +$24K +700 +0.4%
1
2
3 4 5

WX Hedge Fund Activity: Q3 2014 in Review

157 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q3 2014, worth a combined $2B — up 4.7% from $1.91B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new WX positions and 19 closed out — a net gain of 3 holders — while 65 added to existing stakes and 42 trimmed.

The largest buyer was Fidelity International, adding an estimated $55.5M. The largest seller was Mirae Asset Global Investments, cutting an estimated $63.6M.

  • 157 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q3 2014, up from 154 in Q2 2014.
  • Funds reported $2B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q3 2014, up 4.7% quarter-over-quarter.
  • 22 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q3 2014 and 19 closed out, a net change of +3 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q3 2014 was Fidelity International, an estimated $55.5M added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q3 2014 was Mirae Asset Global Investments, an estimated $63.6M sold.

Based on aggregated 13F filings for Q3 2014.